MedTrace Logo

Epigenetics in Lupus Nephritis

NCT04648059 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2022-03-14

No results posted yet for this study

Summary

This is a translational study for the identification of epigenetic changes detectable in sera of patients suffering from Systemic Lupus erythematosus. The aim of the study is to analyze whether circulating DNA fragments are 1) different in patients with or without Lupus nephritis and 2) present and detectable in the circulation before the development of Lupus nephritis.

Conditions

Interventions

DIAGNOSTIC_TEST

Blood sampling

Blood sampling will be performed to allow analyses of epigenetic markers

Sponsors & Collaborators

  • King's College London

    collaborator OTHER

  • Università degli Studi di Brescia

    collaborator OTHER

  • University of Göttingen

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2022-12-31
Completion
2023-06-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04648059 on ClinicalTrials.gov